Stockreport
Computational Biology Market Projected to Reach USD 25.46 Billion by 2032 at 16.80% CAGR, Driven by AI and Genomic Research – SNS Insider [Yahoo! Finance]
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations: illumina.com/company/investor-information.html
Pune, March 18, 2025 (GLOBE NEWSWIRE) -- According to a recent report by SNS Insider, the global Computational Biology Market was valued at USD 6.32 billion in 2023 and is expected to reach USD 25.46 billion by 2032, growing at a compound annual growth rate (CAGR) of 16.80% during the forecast period from 2024 to 2032. This growth is fueled by advancements in bioinformatics, drug discovery, and precision medicine. Market Analysis The use of computational tools in biological studies has transformed the field of biological research, allowing researchers to analyze complex biological data, predict the mechanisms of diseases, and shorten the time for developing new therapeutics. Chronic diseases such as cancer, diabetes, and cardiovascular disorders are on the rise due to the increased aging population, and the need for drug development processes that are cost-effective and efficient are major factors propelling the computational biology market. So, governments and private organizati
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | ILMN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
ILMN alerts
ILMN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
NEWS
NEWS
- Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.[MarketBeat]
- Illumina To Webcast Upcoming Investor Conference[PR Newswire]
- Illumina (NASDAQ:ILMN) had its price target raised by analysts at JPMorgan Chase & Co. from $105.00 to $130.00. They now have a "neutral" rating on the stock.[MarketBeat]
- Illumina (NASDAQ:ILMN) had its "underweight" rating reaffirmed by analysts at Barclays PLC.[MarketBeat]
- Illumina (NASDAQ:ILMN) had its "hold (c-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.[MarketBeat]
- More
ILMN
SEC Filings
SEC Filings
- 12/16/25 - Form 4
- 12/12/25 - Form 144
- 12/9/25 - Form 4
- ILMN's page on the SEC website
- More